GlassScriptPhysician profile
Carl Everett White
NPI 1699385773
$781.06
in general payments reported to CMS, 2019-2025
17 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $560 · 2022: $14.80 · 2023: $17.35 · 2024: $61.94 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $132.09 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.96 | 2021-2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $89.83 | 2021 | |
| Amgen INC. | $85.93 | 2021-2025 | Repatha, Otezla |
| Lilly USA, LLC | $57.60 | 2021 | |
| Biogen, INC. | $40.08 | 2021 | |
| Pfizer INC. | $37.88 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $30.79 | 2021 | |
| Astellas Pharma US INC | $30.73 | 2021 | |
| Glaxosmithkline, LLC. | $30.58 | 2021 | |
| Cleerly, INC. | $21.44 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Amarin Pharma, INC. | $21.29 | 2021 | |
| Phadia US INC. | $20.53 | 2025 | Immunocap |
| Novo Nordisk INC | $19.16 | 2021 | |
| Eisai INC. | $18.53 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.